Scotland Accepts Mitsubishi Pharma Europe’s Exembol

mia.burns Mitsubishi Pharma Europe’s Anticoagulant Exembol (argatroban) Receives Acceptance from the Scottish Medicines Consortium (SMC) as Treatment for Patients with Heparin-induced ...

Australian PM unveils $250M fund to back regenerative med effort

John Carroll You can now count the Australian government as a major supporter of regenerative medicine research. Prime Minister Kevin Rudd has unveiled a $ 250 million public/private ...

GSK Crohn’s disease Trial Misses Primary Endpoint

mia.burns ChemoCentryx Announces GlaxoSmithKline’s Release of Top-Line Results From the SHIELD-1 Phase III Study of Vercirnon MOUNTAIN VIEW, Calif., Aug. 23, 2013 (GLOBE ...

UPDATED: Amgen closing in on $10.5B Onyx buyout

John Carroll Amgen appears close to bagging its biotech prey. After starting out with a $ 120-a-share offer for Onyx, the giant biopharma company appears to have settled on a final ...

Lilly investigating allegations of $4.9M in Chinese bribes

Carly Helfand Eli Lilly, the most recent company targeted with bribery accusations in China, is looking into the matter itself. The company says it is "deeply concerned" by ...

Chris Schneider Takes on Senior Level Strategy Role at Ipsos Healthcare

barbara.lempert Ipsos Healthcare Forecasts Stronger Insights for Pharma Companies New York, NY August 15, 2013– Senior research expert Chris Schneider has joined Ipsos Healthcare ...

FDA Requires Label and Guide Updates for Fluoroquinolone Antibacterials

mia.burns Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage [Posted 08/15/2013] AUDIENCE: Family Practice, Infectious ...

New FDA Guidelines Could Benefit CRO Industry in Research Triangle Park

mia.burns New FDA Guidelines Could Benefit CRO Industry and the Triangle Aug. 16–New federal guidelines that encourage the pharmaceutical industry to consider a non-traditional ...

Final Patient Finishes in Prosonix Phase II Trial for COPD

mia.burns Final Patient Completes Prosonix’ Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) OXFORD, England, August 16, ...

New Report: Adult Obesity Rates Hold Steady But Remain High

mia.burns Rates Top 30 Percent in 13 States, Are Highest in South, Midwest and Among Baby Boomers WASHINGTON, Aug. 15, 2013 /PRNewswire-USNewswire/ — After three decades of ...

USPTO Issues Initial Action on Reexamination of Cadence Pharmaceuticals Patent

mia.burns Cadence Pharmaceuticals Comments on USPTO’s Non-Final, Initial Office Action on Reexamination of Patent SAN DIEGO, Aug. 15, 2013 /PRNewswire/ — Cadence Pharmaceuticals, ...

Japan Approves Astellas IBS Tablets

mia.burns Approval of Irribow® OD Tablets in Japan for Diarrhea-predominant Irritable Bowel Syndrome August 15, 2013 Tokyo, August 15, 2013 – Astellas Pharma Inc. ...
Page 5 of 38« First...34567...102030...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS